Vermue Febe, Sapmaz Aysegul, Berlin Ilana
Oncode Institute and Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.
FLOW Protein Quality for Health, Leiden University Medical Center, Leiden, Netherlands.
Contact (Thousand Oaks). 2025 Jul 28;8:25152564251363050. doi: 10.1177/25152564251363050. eCollection 2025 Jan-Dec.
Execution of all cellular functions depends on a healthy proteome, whose maintenance requires multimodal oversight. Roughly a third of human proteins reside in membranes and thus present unique topological challenges with respect to biogenesis and degradation. To meet these challenges, eukaryotes have evolved organellar pathways of protein folding and quality control. Most transmembrane proteins originate in the endoplasmic reticulum (ER), where they are subject to surveillance and, if necessary, removal through either ER-associated proteasomal degradation (cytosolic pathway) or selective autophagy (ER-phagy; organellar pathway). In the latter case, ER cargoes are shuttled to (endo)lysosomes - the same organelles that degrade cell surface molecules via endocytosis. Here, we provide an overview of dynamic coordination between the ER and endolysosomes, with a focus on their engagement in specialized physical interfaces termed membrane contact sites (MCSs). We cover how cross-compartmental integration through MCSs allows biosynthetic and proteolytic organelles to fine-tune each other's membrane composition, organization, and dynamics and facilitates recovery from proteotoxic stress. Along the way, we highlight recent developments and open questions at the crossroads between organelle biology and protein quality control and cast them against the backdrop of factor-specific diseases associated with perturbed membrane homeostasis.
所有细胞功能的执行都依赖于一个健康的蛋白质组,其维持需要多模式监督。大约三分之一的人类蛋白质存在于膜中,因此在生物合成和降解方面面临独特的拓扑学挑战。为了应对这些挑战,真核生物进化出了蛋白质折叠和质量控制的细胞器途径。大多数跨膜蛋白起源于内质网(ER),在那里它们受到监测,如有必要,通过内质网相关蛋白酶体降解(胞质途径)或选择性自噬(内质网自噬;细胞器途径)被清除。在后一种情况下,内质网货物被转运到(内)溶酶体——通过内吞作用降解细胞表面分子的相同细胞器。在这里,我们概述了内质网和内溶酶体之间的动态协调,重点关注它们在称为膜接触位点(MCSs)的特殊物理界面中的相互作用。我们阐述了通过MCSs进行的跨区室整合如何使生物合成和蛋白水解细胞器能够微调彼此的膜组成、组织和动态,并促进从蛋白毒性应激中恢复。在此过程中,我们强调了细胞器生物学和蛋白质质量控制交叉领域的最新进展和悬而未决的问题,并将它们置于与膜稳态紊乱相关的因子特异性疾病的背景下进行探讨。